HSBC Holdings
RMD icon

HSBC Holdings’s ResMed RMD Stock Holding History

HSBC Holdings’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200
Closed -$11K – 2219
2015
Q4 		$11K Buy
+200
New +$11.3K ﹤0.01% 2210
2015
Q3 		– Sell
-67
Closed -$4K – 2126
2015
Q2 		$4K Buy
+67
New +$4.23K ﹤0.01% 2040
2013
Q3 		– Sell
-5,840
Closed -$264K – 1761
2013
Q2 		$264K Buy
+5,840
New +$277K ﹤0.01% 1365

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSBC Holdings's RMD Position: Q1 2026 in Review

HSBC Holdings reduced its ResMed (RMD) stake by 4.6% in Q1 2026, selling an estimated $3.81M and leaving 313,511 shares worth $70.3M. The position accounts for 0.04% of the portfolio, ranked #422.

HSBC Holdings first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $106M in Q4 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • HSBC Holdings held 313,511 shares of ResMed worth $70.3M as of Q1 2026.
  • HSBC Holdings sold 15,274 ResMed shares in Q1 2026, an estimated $3.81M.
  • ResMed made up 0.04% of HSBC Holdings's portfolio in Q1 2026, its #422 holding.
  • HSBC Holdings first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's ResMed position peaked at $106M in Q4 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.